Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

Temporary ovarian suppression with gonadotropin-releasing hormone agonist during chemotherapy might be a reliable strategy not only to preserve ovarian function but also to increase the likelihood of becoming pregnant after the end of cytotoxic therapy. The findings of Blumenfeld et al. are consiste...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Del Mastro, Lucia, Lambertini, Matteo
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2015
Témata:
Commentary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4718439/
https://ncbi.nlm.nih.gov/pubmed/26463868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0373
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky